Clozapine’s effect on recidivism among offenders with mental disorders

Journal of the American Academy of Psychiatry and the Law

Volumn 44, Issue 1, 2016, Pages 82-90

  Mela, Mansfield ^a   Depiang, Gu ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Regional Psychiatric Centre ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

CONTROLLED STUDY; CRIME; FOLLOW UP; HUMAN; LEGISLATION AND JURISPRUDENCE; OFFENDER; PREVENTION AND CONTROL; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIAL;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; CRIME; CRIMINALS; FOLLOW-UP STUDIES; HUMANS; PSYCHOTIC DISORDERS;

EID: 84959492042     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Swanson J, Estroff S, Swartz M, et al: Violence and severe mental disorder in clinical and community populations: the effects of psychotic symptoms, comorbidity, and lack of treatment. Psychiatry 60:1–22, 1997
2. Taylor PJ: Mental disorder and risk of violence. Int Rev Psychiatry 9:157–162, 1997
3. Swartz MS, Swanson JW, Hiday VA, et al: Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry 155:226-231, 1998
4. Taylor PJ: When symptoms of psychosis drive serious violence. Soc Psychiatry Psychiatr Epidemiol 33(Suppl 1):S47–S54, 1998
5. Tiihonen J, Isohanni M, Rasanen P, et al: Specific major mental disorders and criminality: a 26-year prospective study of the 1966 northern Finland birth cohort. Am J Psychiatry 154:840–845, 1997
6. Taylor PJ, Leese M, Williams D, et al: Mental disorder and violence: a special (high security) hospital study. Br J Psychiatry 172:218-226, 1998
7. Humphreys MS, Johnstone EC, MacMillan JF, et al: Dangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatry 161:501–505, 1992
8. Walsh E, Buchanan A, Fahy T: Violence and schizophrenia: examining the evidence. Br J Psychiatry 180:490–495, 2002
9. Cusack KJ, Morrissey JP, Cuddeback GS, et al: Criminal justice involvement, behavioral health service use, and costs of forensic assertive community treatment: a randomized trial. Community Ment Health J 46:356-363, 2010
10. Cusack KJ, Steadman HJ, Herring AH: Perceived coercion among jail diversion participants in a multisite study. Psychiatr Serv 61:911–916, 2010
11. Walsh E, Gilvarry C, Samele C, et al: Reducing violence in severe mental illness: randomised controlled trial of intensive case management compared with standard care. BMJ 323:1093–1096, 2001
12. Balbuena L, Mela M, Wong S, et al: Does clozapine promote employability and reduce offending among mentally disordered offenders? Can J Psychiatry 55:50-56, 2010
13. Ebrahim GM, Gibler B, Gacono CB, et al: Patient response to clozapine in a forensic psychiatric hospital. Hosp Community Psychiatry 45:271–273, 1994
14. Dalal B, Larkin E, Leese M, et al: Clozapine treatment of longstanding schizophrenia and serious violence: a two-year follow-up study of the first 50 patients treated with clozapine in Rampton high security hospital. Crim Behav Ment Health 9:168-178, 1999
15. Krakowski MI, Czobor P, Nolan KA. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. J Clin Psychopharmacol 28:485-493, 2008
16. Frogley C, Taylor D, Dickens G, et al: A systematic review of the evidence of clozapine’s anti-aggressive effects. Int J Neuropsychopharmacol 15:1351–1371, 2012
17. El-Mallakh RS, McKenzie C: The dopamine D4/D2 receptor antagonist affinity ratio as a predictor of anti-aggression medication efficacy. Med Hypoth 80:530-533, 2013
18. Frankle W, Shera D, Berger-Hershkowitz H, et al: Clozapineassociated reduction in arrest rates of psychotic patients with criminal histories. Am J Psychiatry 158:270-274, 2001
19. Glazer WM, Dickson RA: Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 59(Suppl 3): 8–14, 1998
20. Drake RE, Bond GR, Torrey WC: Psychiatry and rehabilitation. Community Ment Health J 36:617-679, 2000
21. Drake RE, Xie H, McHugo GJ, et al: The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bull 26:441-449, 2000
22. Zimmet SV, Strous RD, Burgess ES, et al: Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol 20:94-98, 2000
23. Kane JM, Aguglia E, Altamura AC, et al: Guidelines for depot antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol 8:55-66, 1998
24. Kane JM, Garcia-Ribera C: Clinical guideline recommendations for antipsychotic long-acting injections. Br J Psychiatry 195:S63-S67, 2009
25. Knabb JJ, Welsh RK, Graham-Howard ML: Treatment alternatives for mentally disordered offenders: a literature review. Psychology 2:122, 2011
26. Fazel S, Zetterqvist J, Larsson H, et al: Antipsychotics, mood stabilisers, and risk of violent crime. Lancet 384:1206-1214, 2014
27. Martin A, O’Driscoll C, Samuels A: Clozapine use in a forensic population in a New South Wales prison hospital. Aust N Z J Psychiatry 42:141–146, 2008
28. Hector RI: The use of clozapine in the treatment of aggressive schizophrenia. Can J Psychiatry 43:466–472, 1998
29. Erickson SK, Ciccone JR, Schwarzkopf SB, et al: Legal fallacies of antipsychotic drugs. J Am Acad Psychiatry Law 35:235–246, 2007
30. Lamberti JS: Understanding and preventing criminal recidivism among adults with psychotic disorders. Psychiatr Serv 58:773-781, 2007
31. Teplin LA: The prevalence of severe mental disorder among male urban jail detainees: comparison with the Epidemiologic Catchment Area Program. Am J Public Health 80:663-669, 1990
32. Teplin LA: Detecting disorder: the treatment of mental illness among jail detainees. J Consult Clin Psychol 58:233–236, 1990
33. Silver SB, Cohen MI, Spodak MK: Follow-up after release of insanity acquittees, mentally disordered offenders, and convicted felons. Bull Am Acad Psychiatry Law 17:387-400, 1989
34. Lovell D, Gagliardi GJ, Peterson PD: Recidivism and use of services among persons with mental illness after release from prison. Psychiatr Serv 53:1290-1296, 2002
35. Hall DL, Miraglia RP, Lee LW: Predictors of general and violent recidivism among SMI prisoners returning to communities in New York State. J Am Acad Psychiatry Law 40:221-231, 2012